The sequence of events leading to definitive adult hematopoiesis in the mouse has long been debated. The traditional notion that yolk-sac-derived stem cells seed the adult compartment has now been challenged by evidence that intra-embryonic stem cells play a crucial role.
During mouse embryogenesis, hematopoiesis begins in the blood islands of the yolk sac at embryonic day 7.5 (E7.5), and then, around E10.5, shifts to the fetal liver and later to the spleen and bone marrow. Blood-cell development prior to the formation of the fetal liver is known as primitive hematopoiesis. The blood islands, which arise in the extra-embryonic mesoderm of the yolk sac, are endothelium-lined spaces filled with large, nucleated blood cells (Fig. 1) . Circulation begins at the eight somite stage, around E8.5, and thereafter primitive blood cells are seen coursing through the large vessels. Blood cells of other lineages -lymphocytes, monocyte/macrophages and platelets -are not detectable at this time, although when embryonic blood is cultured in vitro with appropriate growth factors, progenitor cells of each of these lineages give rise to colonies. In contrast to human embryogenesis, there is no distinct fetal hematopoietic stage during mouse ontogeny and the term 'definitive hematopoiesis' is generally applied to blood production after the formation of the fetal liver.
The yolk sac is the first site in which blood cells are detectable during mouse development, and this led to the classical belief that it is the source of the pluripotent hematopoietic stem cells which migrate to the fetal liver to initiate definitive hematopoiesis. Experimental evidence in support of this hypothesis was provided in 1970 by Metcalf and Moore [1] , who showed that erythroid and myeloid hematopoietic progenitor cells were present in the E8 yolk sac but were not found in body of the embryo. Others subsequently demonstrated that E9 yolk sac could give rise to mast cells, and, under appropriate culture conditions, to T and B lymphocytes. This hypothesis has now been challenged, however, by new evidence that the ontogenetic origin of adult blood cells lies in intra-embryonic stem cells, rather than extra-embryonic yolk-sac cells.
A pre-liver intra-embryonic source of hematopoietic stem cells
Grafting experiments with avian embryos have identified an intra-embryonic source of hematopoietic stem cells which initiate definitive hematopoiesis (reviewed in [2] ). Chick-quail and chick-chick grafting experiments clearly showed that, in birds, definitive hematopoiesis arises from Schematic representation of a longitudinal section of the E8.5 mouse embryo. A yolk-sac blood island and the paraaortic splanchnopleura, the two regions of the embryo in which hematopoietic progenitor cells have been detected prior to the onset of circulation, are enlarged; in the case of the paraaortic splanchnopleura, the enlargement is a transverse section, and the boxed area shows the region used in the experiments of Cumano et al. [6] . YS, yolk sac; Am, amnion. an intra-embryonic region around the dorsal aorta, while yolk-sac-derived cells produce a transient wave of primitive hematopoiesis. Similar findings were obtained for the frog Xenopus, from grafting experiments in which adult hematopoiesis was shown to arise essentially from an intraembryonic region and not from the ventral blood island (the amphibian yolk sac counterpart) [3] . These results led to a search for the site of formation of hematopoietic stem cells within the body of the developing mouse embryo.
Three types of hematopoietic assays are commonly used to identify early hematopoietic cells: in vitro cultures, the colony-forming units-spleen (CFU-S) assay and the longterm repopulating-hematopoietic stem cells (LTR-HSC) assay. For in vitro cultures, hematopoietic progenitor cells are grown in semi-solid medium stimulated with hematopoietic growth factors; T cells are grown in fetal thymus organ cultures, and stromal co-cultures are used to expand B cells. In the CFU-S assay, the cells to be tested are injected into lethally irradiated recipients; the mice are sacrificed 10-15 days later and macroscopic colonies on the surface of their spleen counted. The numbers of CFU-S present in a cell population are a readout for early hematopoietic progenitor cells and are often used as a surrogate assay to detect hematopoietic stem cells. The LTR-HSC assay is currently the gold standard for determining the presence of hematopoietic stem cells. LTR-HSC are measured by injecting genetically distinguishable test cells into lethally irradiated adult mice and assaying their ability to repopulate the blood system over extended periods.
Using these assays, several laboratories identified a preliver intra-embryonic site of hematopoietic activity in the mouse (reviewed in [4] ). In the E7-8 embryo, this region is called the paraaortic splanchnopleura and consists of the caudal splanchnic mesoderm and the endoderm of the developing gut and endothelium of arteries (Fig. 1) . Hematopoietic activity was also detected in a similar region within the body of the E9-11 embryo, known as the AGM as it comprises the aorta, gonads and mesonephros. In the early embryo, yolk sac and paraaortic splanchnopleura were both shown to contain multipotential hematopoietic progenitor cells [5] . CFU-S activity was found in the yolk sac and AGM at late E9, but LTR-HSC activity only became detectable at late E10, and even then LTR-HSC activity at this pre-fetal liver stage was found only at very low frequency (3 out of 97 embryos).
These results demonstrated the presence of cells with hematopoietic potential, including definitive hematopoietic stem cells activity, within the embryo but, because of circulation between the yolk sac and embryo, could not define the site of origin of the definitive hematopoietic stem cells. Two recent studies [6, 7] have now come a step closer to pinpointing the origin of the hematopoietic stem cells that establish definitive hematopoiesis.
Hematopoietic progenitor cells in the precirculation embryo
Cumano et al. [6] undertook a series of elegant experiments which directly addressed the problem that had confounded previous studies -the circulation between the yolk sac and paraaortic splanchnopleura. Yolk sac and caudal paraaortic splanchnopleura were dissected at different embryonic stages before and after the onset of circulation and cultured intact in vitro for two days. The cells were then dispersed and expanded for a further three days, at which time portions of each clone were assayed in separate in vitro cultures optimized for the growth of B cells, T cells and erythroid and myeloid cells. Intriguingly, they found that, before the onset of circulation, all the lymphoid progenitors resided in the paraaortic splanchnopleura region, but that erythroid and myeloid progenitor cells resided in both embryonic tissues. Mixing yolk sac and paraaortic splanchnopleura cells together during culture did not alter their differentiation potential. The yolk-sac-derived myeloid and erythroid progenitor cells were fewer in number and less frequently showed multilineage differentiation compared with clones of paraaortic splanchnopleura origin. CFU-S and LTR-HSC activity was not found in cultured cells from either yolk sac or paraaortic splanchnopleura.
Medvinsky and Dzierzak [7] reanalysed yolk sac, AGM and fetal liver from E9, E10 and E11 embryos for the presence of CFU-S and LTR-HSC. In their new study they isolated tissues and cultured them intact for two to three days, then dispersed and injected the cells into lethally irradiated recipient mice. This dramatically enhanced the number of CFU-S obtained from E10 and E11 AGM. In contrast, the numbers of yolk-sac-derived CFU-S remained low. The most startling observation, however, came from the analysis of LTR-HSC activity. As previously observed, no hematopoietic stem cells activity was detected in E9 embryonic tissues, even after the addition of the in vitro culture step. By E10, however, transplantation of AGM cells, after organotypic culture, resulted in reconstitution of 24 out of 27 recipient mice, assayed at eight months post-transplantation, with donor cells. No mice receiving yolk sac, liver, or body remnant cells, showed any evidence of donor-derived hematopoietic reconstitution.
These studies provide additional evidence that, in the mouse, as in birds, there is an important intra-embryonic site of hematopoiesis, and that the cells with LTR-HSC activity reside in the paraaortic splanchnopleura/AGM region. The classical view, in which stem cells arise in the yolk sac and sequentially colonize the hematopoietic organs can be modified in the light of these recent observations. The new model proposes that blood cells arise in the yolk sac and paraaortic splanchnopleura/AGM around E7.5, mix in the embryonic circulation and at E11 colonize the newly formed liver rudiment. The paraaortic splanchnopleura/AGM region contributes hematopoietic stem Dispatch R11 R12 Current Biology, Vol 7 No 1 cells which go on to establish the definitive hematopoiesis within the fetal liver (Fig. 2) . Many questions remain, however. For example, why is it not possible to detect LTR-HSC prior to E10? What are the crucial cell interactions during the organotypic culture step that enable hematopoietic stem cells determination and/or expansion? What is the relationship between intra-embryonic hematopoietic progenitor cells and intra-embryonic primordial germ cells [8] ?
So is the answer definitive?
Well -not quite yet. The important new findings that the precirculation murine embryo is an independent, nonyolk sac source of hematopoietic progenitor cells and that progenitor cells with lymphoid potential arise exclusively in the intra-embryonic site certainly challenge earlier models. As to whether the yolk sac or the paraaortic splanchnopleura/AGM region is the source of hematopoietic stem cells that seed the fetal liver to initiate definitive hematopoiesis, evidence is steadily mounting to suggest that the AGM, after E9, is a much more potent source of hematopoietic stem cells than the yolk sac. This does not, however, prove beyond reasonable doubt that definitive hematopoiesis arises from the AGM site. Such proof awaits studies in which the yolk sac and Y-Sp/AGM hematopoietic progenitor cells are separately marked and their fate tracked during embryonic development. Development of hematopoiesis in the mouse embryo. Hematopoietic progenitor cells arise in both the blood islands (extra-embryonic) and the paraaortic splanchnopleura (intraembryonic). After the onset of circulation, cells from both regions circulate, forming the primitive hematopoietic system. By E14, these primitive hematopoietic cells are no longer seen. When the fetal liver rudiment develops, around E10, it is colonized by circulating hematopoietic cells arising from both the intraembryonic and extra-embryonic sites. Hematopoietic stem cells, which establish definitive hematopoiesis, most likely originate from the intra-embryonic site, which at this time is known as the AGM region. Hematopoietic stem cells from the fetal liver subsequently colonise the spleen and bone marrow.
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